Press release
Digital platform for evidence-based medical data analysis
medical evidence ai - IMMUMEDIC ( (C) IMMUMEDIC Limited/ Andreas Rach)
Modern medicine generates an enormous amount of data. This includes clinical findings, laboratory values, immune status analyses, diagnostic imaging, and a steadily growing number of scientific publications. It is becoming increasingly challenging for physicians to link these different data sources and take them into account when making medical decisions.
This is where the Medical Evidence AI project comes in. The planned platform aims to bring together various medical information sources in a structured manner and evaluate them using modern analysis technologies. In particular, medical data areas such as medical history, laboratory parameters, immune status, tumor biology, and international scientific studies are to be linked together.
By bringing this information together, a digital infrastructure can be created in the long term that clearly presents complex medical data and supports evidence-based analyses. The focus is on the structured presentation of medical correlations and improved accessibility of scientific findings. Systematic evaluation of medical data is becoming increasingly important, particularly in the field of personalized medicine and precision medicine. Modern medical research is increasingly based on the analysis of large amounts of data and the linking of clinical information with scientific evidence. Digital platform solutions can help to structure this information more efficiently and make it more accessible. Medical Evidence AI is currently being developed by IMMUMEDIC and is currently in the development phase. Significant private funds have already been invested in the project development to establish the conceptual foundations, data structures, and platform architecture. In the long term, the project aims to establish a digital platform for evidence-based medical data analysis that combines medical information, scientific studies, and modern technologies. The aim is to contribute to the further development of data-based medical analyses and to improve the structuring of medical information.
IMMUMEDIC Limited
Bessemerstr. 51 1.OG
12103 Berlin
Germany
https://www.medical-evidence.com/
Andreas Rach
+49 016091942558
immumedic@gmail.com
Medical Evidence AI is a project of IMMUMEDIC and deals with the development of digital solutions for the structured analysis of medical data. The focus is on building a platform that systematically links medical information and scientific findings. The goal is to present complex medical data in a clear manner and enable evidence-based evaluations.
The platform will bring together various medical data sources, including: medical history laboratory values and immune status parameters tumor biology international scientific studies Combining this data with modern analysis methods will create a digital infrastructure that will enable a structured medical data platform in the long term.
The background to the project is the increasing amount of medical information in research and clinical practice. Today, physicians are faced with the challenge of incorporating large amounts of scientific publications and complex medical data into their decisions. Digital platforms can help to make this information more accessible and present correlations in a more structured way.
Medical Evidence AI is currently in the development phase. Significant private funds have already been invested in the project to develop the concept, data structures, and platform architecture. In the long term, the project aims to build a platform that combines medical data analysis, scientific evidence, and digital technologies, thereby contributing to the further development of data-based precision medicine.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Digital platform for evidence-based medical data analysis here
News-ID: 4421971 • Views: …
More Releases from IMMU
Why many people don't understand their immune system - and what the consequences …
A contribution to clarifying the silent intelligence of the human body
The human immune system protects us every day - mostly unnoticed, mostly as a matter of course. It recognizes dangers, distinguishes between "self" and "other", learns from experience and stores memories. Nevertheless, it remains an abstract concept for many people. A system that is only noticed when it no longer functions properly.
A key reason for this lack of understanding is…
The immune system as the key: Dendritic cell therapy opens up new perspectives i …
Individual immunotherapies with dendritic cells (DZT) are increasingly becoming the focus of modern cancer medicine. More and more scientific studies are proving that the body's own immune system - when properly activated - can specifically recognize and fight cancer cells.
Dendritic cells - Nobel Prize, function, scientific basis
Dendritic cells are the 'masters' of the immune system. They present antigens - i.e. characteristics of pathological cells - to the T cells and…
Dendritic cell therapy shows success in lung cancer with metastases.
While conventional oncology often reaches its limits in metastatic lung cancer, modern immunotherapy offers new hope: dendritic cell therapy (DZT) uses the body's own immune intelligence to specifically recognize and combat tumour cells.
Functional principle of dendritic cell therapy
Dendritic cells are considered the "generals" of the immune system.
They present the characteristic antigens of tumour cells to the immune system and thereby activate specific killer cells (T cells), which recognize and destroy…
Cancer & Metastases: The role of apoptosis - and how adjuvant therapies can supp …
Many cancer cells manage to switch off natural cell death - known as apoptosis. It is precisely this "safety mechanism" in the healthy body that ensures that defective cells are broken down in an orderly fashion and replaced by new, healthy cells.
In the case of metastases, it is particularly important to reactivate or support this protective function, as this prevents tumor cells from continuing to multiply uncontrollably.
Apoptosis - simply explained
Think…
More Releases for IMMUMEDIC
The immune system as the key: Dendritic cell therapy opens up new perspectives i …
Individual immunotherapies with dendritic cells (DZT) are increasingly becoming the focus of modern cancer medicine. More and more scientific studies are proving that the body's own immune system - when properly activated - can specifically recognize and fight cancer cells.
Dendritic cells - Nobel Prize, function, scientific basis
Dendritic cells are the 'masters' of the immune system. They present antigens - i.e. characteristics of pathological cells - to the T cells and…
Dendritic cell therapy shows success in lung cancer with metastases.
While conventional oncology often reaches its limits in metastatic lung cancer, modern immunotherapy offers new hope: dendritic cell therapy (DZT) uses the body's own immune intelligence to specifically recognize and combat tumour cells.
Functional principle of dendritic cell therapy
Dendritic cells are considered the "generals" of the immune system.
They present the characteristic antigens of tumour cells to the immune system and thereby activate specific killer cells (T cells), which recognize and destroy…
Cancer & Metastases: The role of apoptosis - and how adjuvant therapies can supp …
Many cancer cells manage to switch off natural cell death - known as apoptosis. It is precisely this "safety mechanism" in the healthy body that ensures that defective cells are broken down in an orderly fashion and replaced by new, healthy cells.
In the case of metastases, it is particularly important to reactivate or support this protective function, as this prevents tumor cells from continuing to multiply uncontrollably.
Apoptosis - simply explained
Think…
Combination therapies against the five most dangerous cancers - hope for sustain …
Cancer continues to be one of the biggest health challenges worldwide. In particular, tumor types such as lung cancer, breast cancer, pancreatic cancer, colorectal cancer and aggressive glioblastoma are considered the most dangerous and most common forms of cancer. Despite advances in diagnostics and therapy, treatment remains complex, especially when metastases occur.
However, medical innovations show that optimal combination therapies open up new perspectives: Through the targeted interaction of surgical interventions,…
Why waiting for a diagnosis of "metastases is dangerous?
Why waiting is dangerous - New hope for metastases through immunotherapy with dendritic cells and "ImmuSeroForte"
The appearance of metastases in cancer is a shock for many patients and their relatives. In breast cancer in particular, but also in other types of tumor, metastases are often the turning point of the disease - they can become life-threatening.
But an important message is: waiting is not an option. The faster action is taken,…
Cancer in the workplace: How companies can support employees
Supporting employees during their illness - and why this is also economically worthwhile
A cancer diagnosis changes life abruptly - not only for those affected, but also for those around them. The workplace in particular plays a central role during this time. More and more companies are realizing that actively supporting sick employees is not only a human gesture, but can also make good business sense.
Health is an economic factor
Around half…
